Last update 29 Nov 2024

Vebeglogene Autotemcel

Overview

Basic Info

Drug Type
AAV based gene therapy
Synonyms
Autologous CD34+HSCs, Beta-globin lentiviral vector transduced autologous HSCs
Target
β-globin
Mechanism
HBB gene modulators(Hemoglobin beta chain gene modulators)
Therapeutic Areas
Congenital DisordersHemic and Lymphatic DiseasesOther Diseases
Active Indication
Beta-ThalassemiaTransfusion-dependent Beta Thalassemia
Inactive Indication-
Originator Organization
Lantu Biopharma Inc.
Active Organization
Lantu Biopharma Inc.
Inactive Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Vebeglogene Autotemcel
NCT06308159 / RecruitingPhase 1/2
An Open-label Clinical Trial of Ex Vivo Beta-globin Lentiviral Vector Transduction of Autologous CD34+HSPCs (Vebeglogene Autotemcel) for the Treatment of Transfusion Dependent Beta-thalassemia Patients
100 Clinical Results associated with Vebeglogene Autotemcel
Login to view more data
100 Translational Medicine associated with Vebeglogene Autotemcel
Login to view more data
100 Patents (Medical) associated with Vebeglogene Autotemcel
Login to view more data
100 Deals associated with Vebeglogene Autotemcel
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Beta-ThalassemiaPhase 2
CN
Lantu Biopharma Inc.
11 May 2024
Transfusion-dependent Beta ThalassemiaPhase 2
CN
Lantu Biopharma Inc.
11 May 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free